Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders
Fréneaux, E.; Pessayre, D.
Gastroenterologie Clinique et Biologique 17(5 Part 2): H36-H43
1993
ISSN/ISBN: 0399-8320 PMID: 8243916 Document Number: 414562
Document emailed within 1 workday
Related Documents
Mal'tsev, A.N.; Levé, O.I.; Sadovnichiĭ, V.V.; Buko, V.U. 2001: Antioxidant effect of prostaglandin E2 in the liver alcoholic steatosis Eksperimental'naia i Klinicheskaia Farmakologiia 64(3): 61-63Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Sergiacomo, L.; Ciancaglini, R.; Orlando, D.; Delle Monache, G.; Pesa, O. 1986: Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study La Clinica Terapeutica 119(2): 133-141
Vancova, O.; Ulicna, O.; Horecky, J.; Zeljenkova, D.; Wimmerova, S.; Trnovec, T. 2000: Liver steatosis and disorders of mitochondrial oxidative phosphorylation after experimental administration of simazine Bratislavske Lekarske Listy 101(8): 423-428
Whelan, G.; Peters, M.; Desmond, P.V.; Bhathal, P.S. 1982: Alcohol unrelated hepato-biliary disorders in the alcoholic: the role of liver biopsy in determining the aetiology of liver disease Australian and New Zealand Journal of Medicine 12(1): 34-38
Bedossa, P.; Lemaigre, G.; Martin, E. 1989: Alcoholic pancreatic steatosis Gastroenterologie Clinique et Biologique 13(6-7): 642-643
Hagymási, K.; Fehér, J.án. 2005: Non-alcoholic steatosis/steatohepatitis Orvosi Hetilap 146(28): 1494-1495
Boustière, C.; Gauthier, A. 1985: Non-alcoholic hepatic steatosis Presse Medicale 14(20): 1147-1150
Caballería Rovira, Lç.; Torán Montserrat, P.; Auladell Llorens, Mía.Antonia.; Pera Blanco, G. 2008: Non-alcoholic hepatic steatosis. An update Atencion Primaria 40(8): 419-424
Fléjou, J.F.; Degott, C.; Kharsa, G.; Soulier, A.; Rueff, B.; Potet, F. 1987: Alcoholic foamy steatosis: study of 3 cases Gastroenterologie Clinique et Biologique 11(2): 165-168
Musto, D.; Martorelli, L.; Russo, M.; Esposito, G.; Amato, M.R.; Esposito, P.; Riegler, G. 2010: Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia Minerva Gastroenterologica e Dietologica 56(4): 389-395
Schlienger, J.L.; Willemin, B.; North, M.L.; Simon, C. 1984: Alcoholic steatosis and cirrhosis. Evaluation of protein-calorie malnutrition Presse Medicale 13(1): 46-47
Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
Wang, Q.; Hollinger, M.A.; Giri, S.N. 1992: Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment Journal of Pharmacology and Experimental Therapeutics 262(1): 127-132
Bokhan, N.A.; Abolonin, A.F.; Ankudinova, I.É; Kurgak, D.I.; Mandel', A.I. 2012: Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage Terapevticheskii Arkhiv 84(10): 51-55
Pár, A.; Horváth, T.; Beró, T.; Kádas, I.; Pakodi, F.; Jávor, T. 1984: Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease Acta Physiologica Hungarica 64(3-4): 449-454
Nilius, R.; Königstedt, B.; Zipprich, B.; Busse, H.J.; Lorenz, G. 1982: Acetaldehyde-induced leukocyte migration inhibition in alcoholic liver diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(12): 393-397
Pagano, A.B.; Vecchio, C.; Giangreco, E.; Neri, S. 2012: Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects La Clinica Terapeutica 163(3): 205-210
Stel'makh, V.V.; Trashkov, A.P.; Kovalenko, A.L.; Zaplutanov, V.A. 2016: Experimental Assessment of the Specific Efficiency of new Metabolic Drug Runikhol on Models of Non-Alcoholic Fatty Liver Disease Eksperimental'naia i Klinicheskaia Farmakologiia 79(10): 13-17
Bannister, P.; Oakes, J.; Sheridan, P.; Losowsky, M.S. 1987: Sex hormone changes in chronic liver disease: a matched study of alcoholic versus non-alcoholic liver disease Quarterly Journal of Medicine 63(240): 305-313